[go: up one dir, main page]

AU2001269468A1 - Alpha-synuclein binding protein - Google Patents

Alpha-synuclein binding protein

Info

Publication number
AU2001269468A1
AU2001269468A1 AU2001269468A AU6946801A AU2001269468A1 AU 2001269468 A1 AU2001269468 A1 AU 2001269468A1 AU 2001269468 A AU2001269468 A AU 2001269468A AU 6946801 A AU6946801 A AU 6946801A AU 2001269468 A1 AU2001269468 A1 AU 2001269468A1
Authority
AU
Australia
Prior art keywords
alpha
binding protein
synuclein binding
synuclein
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269468A
Inventor
Kunimasa Arima
Abdul Alim Muhammad
Kenji Ueda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of AU2001269468A1 publication Critical patent/AU2001269468A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2001269468A 2000-07-06 2001-07-06 Alpha-synuclein binding protein Abandoned AU2001269468A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000205032 2000-07-06
JP2000-205032 2000-07-06
PCT/JP2001/005890 WO2002004625A1 (en) 2000-07-06 2001-07-06 α-SYNUCLEIN BINDING PROTEIN

Publications (1)

Publication Number Publication Date
AU2001269468A1 true AU2001269468A1 (en) 2002-01-21

Family

ID=18702186

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269468A Abandoned AU2001269468A1 (en) 2000-07-06 2001-07-06 Alpha-synuclein binding protein

Country Status (2)

Country Link
AU (1) AU2001269468A1 (en)
WO (1) WO2002004625A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2406279T1 (en) 2009-03-09 2016-04-29 Ramot At Tel-Aviv University Ltd. Compositions for prevention and treatment of neurodegenerative diseases
CN111487414A (en) * 2019-01-29 2020-08-04 北京现代高达生物技术有限责任公司 SNCG/SCC-Ag joint inspection colloidal gold test strip and preparation method and application thereof

Also Published As

Publication number Publication date
WO2002004625A1 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
AU2002247826A1 (en) Specific binding members
IL161418A0 (en) Direct targeting binding proteins
GB0001704D0 (en) Protein
AU2743400A (en) Nucleic-acid binding proteins
GB9928950D0 (en) Binding protein
GB0011185D0 (en) Protein
AU2001259450A1 (en) Cytoskeleton-associated proteins
GB0024446D0 (en) Protein
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2001244863A1 (en) Apoptin-associating protein
AU2001269468A1 (en) Alpha-synuclein binding protein
AU2002211475A1 (en) Site-specific protein modification
GB0119446D0 (en) Binding proteins
GB0009181D0 (en) Protein
AU2001241044A1 (en) Mitf-associated proteins
AU2001278777A1 (en) Irap-binding protein
AU2001271843A1 (en) Gtp-binding proteins
AU2001263445A1 (en) Methods for protein design
IL150774A0 (en) Apoptin-associating protein
AU2001294911A1 (en) Carbohydrate-associated proteins
AU2002324847A1 (en) Dna binding protein
AU2001277614A1 (en) Novel proteins
GB0126888D0 (en) Binding protein
GB0020345D0 (en) Protein
GB0008549D0 (en) Protein